The partnership aims to develop breathing machines and other medical devices complying with international standards and certifications. Furthermore, US and international authorities will approve their products.The agreement contains the norms regarding the approval, licensing, production, marketing, sales etc. However, MX will have the rights to market the products in Indian market. Most recently, the companies had jointly developed the High Flow oxygen Therapy (HFOT) device. The device is offers 100% guarantee to the covid patient and is available at reasonable price in the market.
The collaboration with Amptron Medical will boost the company’s strength in developing more Ventilator allowing meeting its surging demand due to covid. The development of the life-saving devices in collaboration with US will imperative for developing quality products. The joint venture will allow marketing the products globally and expansion in developed markets.
Both the partners look forward to creating mutually beneficial collaborative relationships. The partnership aims to develop breathing machines and other medical devices complying with international standards and certifications. As the medical infrastructure and research team is based on United States, the US and international authorities will approve their products post which will be marketed in the US and other markets.